Cargando…
COVID-19 Cytokine Storm in Myasthenia Gravis Treated with Mesenchymal Stem Cells: The First Philippine Experience
INTRODUCTION: Coronavirus disease 2019 (COVID-19) continues to plague especially the immunocompromised, and yet little is known regarding its treatment on patients who present clinically similar like those with Myasthenia Gravis (MG) in crisis. METHODS: We examined the case of a patient with MG seco...
Autores principales: | Olano, Aldanica R., Sta Maria, Mark Anthony J., Maylem, Genica Lynne C., Buensalido, Marc Joseph Oliver V., Henson, Karl Evans R., Reyes-Calavera, Alma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216624/ http://dx.doi.org/10.1016/j.nerep.2022.100106 |
Ejemplares similares
-
Changes in inflammatory cytokine networks in myasthenia gravis
por: Uzawa, Akiyuki, et al.
Publicado: (2016) -
Thymectomy for myasthenia gravis
por: Moorehead, R J, et al.
Publicado: (1985) -
Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007) -
Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011) -
Myasthenia Gravis
Publicado: (1905)